Tracey Roberts

Profile photo of Tracey Roberts
Tracey graduated from Nottingham Trent University with an MSc by Research in Neuroscience, and has degrees from the University of Aberystwyth and the Open University. She works as the Editorial Assistant at the Cochrane Schizophrenia Group.

Website

Follow me here –

  • Badge_clarity

Antipsychotic efficacy measured by real-world observational study

31 Responses »
Profile photo of Tracey Roberts
Posted by
telescope-1082091_640

Tracey Roberts examines whether a retrospective observational study accurately investigates the effectiveness of second and first generation antipsychotics.

[read the full story...]

Long-acting injectable paliperidone palmitate for schizophrenia

40 Responses »
Profile photo of Tracey Roberts
Posted by
2195975039_d957bacec2_b

Tracey Roberts summarises a recent RCT of the efficacy and safety of paliperidone palmitate 3-month formulation for patients with schizophrenia.

[read the full story...]

Group psychotherapies for schizophrenia

60 Responses »
Profile photo of Tracey Roberts
Posted by
5162224869_52c70e9861_o

Tracey Roberts appraises a systematic review of group psychotherapies for schizophrenia, which includes group CBT, music therapy, art therapy and social skills training.

[read the full story...]

Can early improvement be used to predict later response to antipsychotics in schizophrenia?

31 Responses »
Profile photo of Tracey Roberts
Posted by
The increased risk of mood and anxiety problems found in people taking varenicline with pre-existing mental health conditions, needs to be investigated further.

Tracey Roberts summarises a recent diagnostic test review, which suggests that early improvement can act as a predictor of later response to antipsychotics in schizophrenia.

[read the full story...]

Switching antipsychotics in schizophrenia: the OPTiMiSE RCT

51 Responses »
Profile photo of Tracey Roberts
Posted by
shutterstock_93305014

Tracey Roberts summarises a recent paper that reviews the existing literature concerned with switching antipsychotics in patients with schizophrenia, and goes on to present the ongoing OPTiMiSE RCT in this field, which is due to be published in 2016.

[read the full story...]